| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 13.453 | 190.060 | 313.039 | 440.942 | 452.368 | 683.277 | 780.677 | 837.624 | 933.983 |
| Total Income - EUR | - | 13.764 | 191.022 | 313.040 | 440.942 | 452.368 | 683.278 | 780.680 | 837.632 | 933.985 |
| Total Expenses - EUR | - | 28.601 | 178.311 | 276.272 | 381.229 | 382.277 | 582.093 | 693.531 | 720.939 | 835.256 |
| Gross Profit/Loss - EUR | - | -14.837 | 12.711 | 36.768 | 59.713 | 70.091 | 101.185 | 87.148 | 116.694 | 98.729 |
| Net Profit/Loss - EUR | - | -14.986 | 9.812 | 33.657 | 55.378 | 66.270 | 94.489 | 79.496 | 105.997 | 87.031 |
| Employees | - | 3 | 5 | 7 | 7 | 5 | 7 | 9 | 9 | 9 |
Check the financial reports for the company - Alas Derma Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 43.138 | 40.047 | 77.428 | 107.043 | 85.707 | 83.669 | 68.366 | 73.432 | 63.772 |
| Current Assets | - | 784 | 7.493 | 9.559 | 24.878 | 39.014 | 55.972 | 40.705 | 57.742 | 59.756 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 128 | 738 | 713 | 3.004 | 3.482 | 2.899 | 5.420 | 13.243 | 15.404 |
| Cash | - | 656 | 6.756 | 8.846 | 21.874 | 35.532 | 53.072 | 35.286 | 44.498 | 44.352 |
| Shareholders Funds | - | -14.941 | -4.876 | 28.871 | 55.429 | 66.320 | 94.537 | 79.544 | 106.456 | 104.438 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 60.107 | 52.416 | 58.116 | 80.029 | 59.859 | 45.403 | 29.527 | 24.717 | 19.090 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alas Derma Medical S.r.l.